Uses and sources of data on long-term survival after blood transfusion (Q30814211)

26 June 2017

1 reference

title

Uses and sources of data on long-term survival after blood transfusion (English)

1 reference

26 June 2017

author name string

Eleftherios C Vamvakas

series ordinal

1 reference

26 June 2017

publication date

1 July 2003

1 reference

Transfusion Medicine Reviews

26 June 2017

published in

1 reference

26 June 2017

1 reference

26 June 2017

1 reference

26 June 2017

page(s)

194-208

1 reference

Mortality after blood transfusion

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

The transfused population of Canterbury, New Zealand, and its mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Long-term survival after blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Length of survival after perioperative transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Value and cost‐effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window‐phase human immunodeficiency virus type 1 infections

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Estimating the incubation time distribution and expected number of cases of transfusion-associated acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Estimating the risks of transfusion-associated acquired immune deficiency syndrome and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Long-term survival in transfusion recipients in Sweden, 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Four-year survival of transfusion recipients identified by hepatitis C lookback

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Long-term survival of transfusion recipients in Sweden, 1993

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Transmission of HCV infection by RIBA indeterminate and positive blood units

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Completed hepatitis C lookback in Northern Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Look-back study of infectivity of anti-HCV ELISA-positive blood components

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Hepatitis C virus transmission, 1988-1991, via blood components from donors subsequently found to be anti-HCV-positive

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Transmission of hepatitis C virus by transfusion in Orebro County, Sweden, 1990-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Outcome of post-transfusion hepatitis C: disease severity in blood-component recipients and their implicated donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Look back on hepatitis C-virus infections of HCV-RIBA-2-positive blood donors and their respective recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Transfusion-acquired hepatitis C: the Danish lookback experience. The Danish HCV [hepatitis C virus] Lookback Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Risk of hepatitis C in patients who received blood from donors subsequently shown to be carriers of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Evaluation of the effectiveness of targeted lookback for HCV infection in the United States-interim results

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Targeted hepatitis C lookback: Quebec, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

HCV lookback in the United States: effectiveness of an extended lookback program

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Antibody to Hepatitis C Virus among Cardiac Surgery Patients, Homosexual Men, and Intravenous Drug Users in Baltimore, Maryland

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Look-back: preliminary experience of AABB members. American Association of Blood Banks

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

A matter for debate: the risk of bovine spongiform encephalopathy to humans posed by blood transfusion in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Public health, public trust, and public decision making: making hepatitis C virus lookback work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Acquired immunodeficiency syndrome (AIDS) associated with transfusions.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

Ten-year survival of transfusion recipients identified by hepatitis C lookback

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2803%2900019-1

7 January 2021

10.1016/S0887-7963(03)00019-1

Identifiers

DOI

1 reference

26 June 2017

1 reference